+91 8766 590 1366 sales@chemreports.com

Your Order

Home Reports

Abiraterone Acetate API Global Market

Abiraterone Acetate API Global Market

Global Abiraterone Acetate API Market Industry Research Report 2026

Explore detailed insights, trends, growth drivers, key players, and forecasts for the Global Abiraterone Acetate API Market Industry Research Report 2026 market worldwide.

Pages: 210

Format: PDF

Date: 01-2026

Select Licence

Description Table of Content Key Players & Segment Request for Free Sample

Global Abiraterone Acetate API Market Report (2026–2036)

Market Overview

Chem Reports projects that the Abiraterone Acetate API Market, valued at USD xxxx units in 2025, is expected to reach USD xxxx units by 2036, growing at a CAGR of xx% globally.

The Global Abiraterone Acetate API Market Report 2025 provides an extensive industry analysis of development drivers, market patterns, flows, and sizes. It calculates present and historical market values to forecast potential market performance during 2026–2036. This research integrates both primary and secondary data sources, examining government policies, market environment, competitive landscape, historical data, current trends, technological innovation, upcoming technologies, and technical progress in related industries.

Impact of COVID-19

Since the outbreak of COVID-19 in December 2019, the pandemic has spread worldwide, with the World Health Organization declaring it a public health emergency. The global impacts of COVID-19 significantly affected the Abiraterone Acetate API market in 2020, disrupting supply chains, altering demand patterns, and reshaping investment priorities across pharmaceutical manufacturing and oncology drug supply chains.

Market Segmentation

By Type

  • Purity ≥ 98%
  • Purity ≥ 99%

By Application

  • Abiraterone Acetate Tablets
  • Abiraterone Acetate Capsules
  • Others

Regional Analysis

  • North America: U.S., Canada, Mexico
  • Europe: Germany, U.K., France, Italy, Russia, Spain, others
  • Asia-Pacific: China, India, Japan, Southeast Asia, others
  • South America: Brazil, Argentina, others
  • Middle East & Africa: Saudi Arabia, South Africa, others

Competitive Landscape

Top key players covered in the Abiraterone Acetate API market include:

  • Cipla
  • Tapi Teva
  • HETERO
  • Sterling S.P.A. IT
  • Farmhispania Group
  • Scion Pharm Taiwan
  • Qilu Pharmaceutical
  • Aurisco Pharmaceutical
  • Aspen Bio Pharma Labs
  • Shilpa Medicare Limited
  • Shandong Chuangxin Pharmaceutical Research and Development
  • Zhejiang Xianju Junye Pharmaceutical
  • Wuhan Sunrise Technology Development

Global Abiraterone Acetate API Market Intelligence Brief (2026–2036)

Short Description / Definition

Abiraterone Acetate is an oral androgen biosynthesis inhibitor API, widely used in tablet and capsule formulations for the treatment of metastatic castration-resistant prostate cancer (mCRPC). It works by selectively inhibiting CYP17, a critical enzyme in androgen production. The market is shaped by oncology demand, regulatory compliance, and pharmaceutical innovation, particularly in generics and hospital-based treatments.

Regional Analysis

  • North America: Strong demand in oncology APIs, with the U.S. leading due to FDA oversight, advanced healthcare infrastructure, and high prostate cancer prevalence.
  • Europe: Growth driven by generics and strict EMA regulations. Germany, France, and Italy are key hubs for oncology drug manufacturing.
  • Asia-Pacific: Fastest-growing region, led by China and India, supported by large-scale generic production and government healthcare initiatives.
  • South America: Moderate growth, with Brazil showing demand in oncology treatments.
  • Middle East & Africa: Emerging adoption in oncology care, though market penetration remains limited compared to other regions.

Porter’s Five Forces

  1. Competitive Rivalry: High; global players (Cipla, Teva, HETERO, Farmhispania, Qilu, Aurisco, Shilpa Medicare) compete with regional manufacturers.
  2. Threat of New Entrants: Moderate; entry barriers include GMP compliance, regulatory approvals, and capital-intensive production.
  3. Bargaining Power of Suppliers: Moderate; raw material suppliers hold leverage due to limited sources of intermediates.
  4. Bargaining Power of Buyers: High; hospitals and oncology centers demand cost-effective, compliant APIs.
  5. Threat of Substitutes: Moderate; alternative androgen biosynthesis inhibitors exist, but Abiraterone remains relevant due to established efficacy.

SWOT Analysis

Strengths

  • Established use in prostate cancer treatment.
  • Strong demand in hospital oncology care.
  • Proven efficacy as a CYP17 inhibitor.

Weaknesses

  • High production and compliance costs.
  • Dependence on complex synthesis pathways.

Opportunities

  • Rising global prostate cancer prevalence.
  • Growth in Asia-Pacific generic manufacturing.
  • Development of combination therapies with Abiraterone (e.g., with prednisone or other hormonal agents).

Threats

  • Raw material price volatility.
  • Stringent regulatory hurdles.
  • Competition from newer androgen biosynthesis inhibitors (e.g., Enzalutamide, Apalutamide).

Trend Analysis

  • Increasing use in oncology APIs for prostate cancer.
  • Rising demand in generic formulations across Asia-Pacific.
  • Growth in tablet and capsule formulations for outpatient care.
  • Expansion of pharmaceutical R&D in combination therapies and resistance management.

Drivers & Challenges

Drivers

  • Expanding global oncology drug market.
  • Rising prevalence of prostate cancer worldwide.
  • Technological advancements in API manufacturing.

Challenges

  • High R&D and compliance costs.
  • Regulatory restrictions on oncology APIs.
  • Supply chain disruptions for raw materials.

Value Chain Analysis

  • Raw Materials: Specialized intermediates, solvents.
  • Manufacturing: API synthesis, purification, GMP compliance.
  • Distribution: Global distributors, pharmaceutical partnerships.
  • End-Use Industries: Pharmaceuticals, hospitals, oncology centers.
  • Regulatory Bodies: FDA, EMA, WHO shaping compliance requirements.

Quick Recommendations for Stakeholders

  • Manufacturers: Invest in R&D for cost-efficient production and combination therapies.
  • Investors: Focus on Asia-Pacific oncology markets where growth potential is strongest.
  • Regulators: Support harmonized global standards for oncology APIs.
  • Pharma Companies: Collaborate with API suppliers to ensure compliance and cost efficiency.
  • Distributors: Expand presence in emerging markets with campaigns highlighting therapeutic relevance.

Explore more reports here-

https://chemreports.com/reports

 

1. Market Overview of Abiraterone Acetate API
    1.1 Abiraterone Acetate API Market Overview
        1.1.1 Abiraterone Acetate API Product Scope
        1.1.2 Market Status and Outlook
    1.2 Abiraterone Acetate API Market Size by Regions:
    1.3 Abiraterone Acetate API Historic Market Size by Regions
    1.4 Abiraterone Acetate API Forecasted Market Size by Regions
    1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth
        1.5.1 North America
        1.5.2 East Asia
        1.5.3 Europe
        1.5.4 South Asia
        1.5.5 Southeast Asia
        1.5.6 Middle East
        1.5.7 Africa
        1.5.8 Oceania
        1.5.9 South America
        1.5.10 Rest of the World
    1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
        1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2025 Projections
        1.6.2 Covid-19 Impact: Commodity Prices Indices
        1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Abiraterone Acetate API Sales Market by Type
    2.1 Global Abiraterone Acetate API Historic Market Size by Type
    2.2 Global Abiraterone Acetate API Forecasted Market Size by Type
    2.3 Purity ? 98 %
    2.4 Purity ? 99 %
3. Covid-19 Impact Abiraterone Acetate API Sales Market by Application
    3.1 Global Abiraterone Acetate API Historic Market Size by Application
    3.2 Global Abiraterone Acetate API Forecasted Market Size by Application
    3.3 Abiraterone Acetate Tablets
    3.4 Abiraterone Acetate Capsules
    3.5 Others
4. Covid-19 Impact Market Competition by Manufacturers
    4.1 Global Abiraterone Acetate API Production Capacity Market Share by Manufacturers
    4.2 Global Abiraterone Acetate API Revenue Market Share by Manufacturers
    4.3 Global Abiraterone Acetate API Average Price by Manufacturers
5. Company Profiles and Key Figures in Abiraterone Acetate API Business
    5.1 Cipla
        5.1.1 Cipla Company Profile
        5.1.2 Cipla Abiraterone Acetate API Product Specification
        5.1.3 Cipla Abiraterone Acetate API Production Capacity, Revenue, Price and Gross Margin
    5.2 Tapi Teva
        5.2.1 Tapi Teva Company Profile
        5.2.2 Tapi Teva Abiraterone Acetate API Product Specification
        5.2.3 Tapi Teva Abiraterone Acetate API Production Capacity, Revenue, Price and Gross Margin
    5.3 HETERO
        5.3.1 HETERO Company Profile
        5.3.2 HETERO Abiraterone Acetate API Product Specification
        5.3.3 HETERO Abiraterone Acetate API Production Capacity, Revenue, Price and Gross Margin
    5.4 Sterling S.P.A. IT
        5.4.1 Sterling S.P.A. IT Company Profile
        5.4.2 Sterling S.P.A. IT Abiraterone Acetate API Product Specification
        5.4.3 Sterling S.P.A. IT Abiraterone Acetate API Production Capacity, Revenue, Price and Gross Margin
    5.5 Farmhispania Group
        5.5.1 Farmhispania Group Company Profile
        5.5.2 Farmhispania Group Abiraterone Acetate API Product Specification
        5.5.3 Farmhispania Group Abiraterone Acetate API Production Capacity, Revenue, Price and Gross Margin
    5.6 Scion Pharm Taiwan
        5.6.1 Scion Pharm Taiwan Company Profile
        5.6.2 Scion Pharm Taiwan Abiraterone Acetate API Product Specification
        5.6.3 Scion Pharm Taiwan Abiraterone Acetate API Production Capacity, Revenue, Price and Gross Margin
    5.7 Qilu Pharmaceutial
        5.7.1 Qilu Pharmaceutial Company Profile
        5.7.2 Qilu Pharmaceutial Abiraterone Acetate API Product Specification
        5.7.3 Qilu Pharmaceutial Abiraterone Acetate API Production Capacity, Revenue, Price and Gross Margin
    5.8 Aurisco Pharmaceutical
        5.8.1 Aurisco Pharmaceutical Company Profile
        5.8.2 Aurisco Pharmaceutical Abiraterone Acetate API Product Specification
        5.8.3 Aurisco Pharmaceutical Abiraterone Acetate API Production Capacity, Revenue, Price and Gross Margin
    5.9 Aspen Bio Pharma Labs
        5.9.1 Aspen Bio Pharma Labs Company Profile
        5.9.2 Aspen Bio Pharma Labs Abiraterone Acetate API Product Specification
        5.9.3 Aspen Bio Pharma Labs Abiraterone Acetate API Production Capacity, Revenue, Price and Gross Margin
    5.10 Shilpa Medicare Limited
        5.10.1 Shilpa Medicare Limited Company Profile
        5.10.2 Shilpa Medicare Limited Abiraterone Acetate API Product Specification
        5.10.3 Shilpa Medicare Limited Abiraterone Acetate API Production Capacity, Revenue, Price and Gross Margin
    5.11 Shandong Chuangxin Pharmaceutical Research and Development
        5.11.1 Shandong Chuangxin Pharmaceutical Research and Development Company Profile
        5.11.2 Shandong Chuangxin Pharmaceutical Research and Development Abiraterone Acetate API Product Specification
        5.11.3 Shandong Chuangxin Pharmaceutical Research and Development Abiraterone Acetate API Production Capacity, Revenue, Price and Gross Margin
    5.12 Zhejiang Xianju Junye Pharmaceutical
        5.12.1 Zhejiang Xianju Junye Pharmaceutical Company Profile
        5.12.2 Zhejiang Xianju Junye Pharmaceutical Abiraterone Acetate API Product Specification
        5.12.3 Zhejiang Xianju Junye Pharmaceutical Abiraterone Acetate API Production Capacity, Revenue, Price and Gross Margin
    5.13 Wuhan Sunrise Technology Development
        5.13.1 Wuhan Sunrise Technology Development Company Profile
        5.13.2 Wuhan Sunrise Technology Development Abiraterone Acetate API Product Specification
        5.13.3 Wuhan Sunrise Technology Development Abiraterone Acetate API Production Capacity, Revenue, Price and Gross Margin
6. North America
    6.1 North America Abiraterone Acetate API Market Size
    6.2 North America Abiraterone Acetate API Key Players in North America
    6.3 North America Abiraterone Acetate API Market Size by Type
    6.4 North America Abiraterone Acetate API Market Size by Application
7. East Asia
    7.1 East Asia Abiraterone Acetate API Market Size
    7.2 East Asia Abiraterone Acetate API Key Players in North America
    7.3 East Asia Abiraterone Acetate API Market Size by Type
    7.4 East Asia Abiraterone Acetate API Market Size by Application
8. Europe
    8.1 Europe Abiraterone Acetate API Market Size
    8.2 Europe Abiraterone Acetate API Key Players in North America
    8.3 Europe Abiraterone Acetate API Market Size by Type
    8.4 Europe Abiraterone Acetate API Market Size by Application
9. South Asia
    9.1 South Asia Abiraterone Acetate API Market Size
    9.2 South Asia Abiraterone Acetate API Key Players in North America
    9.3 South Asia Abiraterone Acetate API Market Size by Type
    9.4 South Asia Abiraterone Acetate API Market Size by Application
10. Southeast Asia
    10.1 Southeast Asia Abiraterone Acetate API Market Size
    10.2 Southeast Asia Abiraterone Acetate API Key Players in North America
    10.3 Southeast Asia Abiraterone Acetate API Market Size by Type
    10.4 Southeast Asia Abiraterone Acetate API Market Size by Application
11. Middle East
    11.1 Middle East Abiraterone Acetate API Market Size
    11.2 Middle East Abiraterone Acetate API Key Players in North America
    11.3 Middle East Abiraterone Acetate API Market Size by Type
    11.4 Middle East Abiraterone Acetate API Market Size by Application
12. Africa
    12.1 Africa Abiraterone Acetate API Market Size
    12.2 Africa Abiraterone Acetate API Key Players in North America
    12.3 Africa Abiraterone Acetate API Market Size by Type
    12.4 Africa Abiraterone Acetate API Market Size by Application
13. Oceania
    13.1 Oceania Abiraterone Acetate API Market Size
    13.2 Oceania Abiraterone Acetate API Key Players in North America
    13.3 Oceania Abiraterone Acetate API Market Size by Type
    13.4 Oceania Abiraterone Acetate API Market Size by Application
14. South America
    14.1 South America Abiraterone Acetate API Market Size
    14.2 South America Abiraterone Acetate API Key Players in North America
    14.3 South America Abiraterone Acetate API Market Size by Type
    14.4 South America Abiraterone Acetate API Market Size by Application
15. Rest of the World
    15.1 Rest of the World Abiraterone Acetate API Market Size
    15.2 Rest of the World Abiraterone Acetate API Key Players in North America
    15.3 Rest of the World Abiraterone Acetate API Market Size by Type
    15.4 Rest of the World Abiraterone Acetate API Market Size by Application
16 Abiraterone Acetate API Market Dynamics
    16.1 Covid-19 Impact Market Top Trends
    16.2 Covid-19 Impact Market Drivers
    16.3 Covid-19 Impact Market Challenges
    16.4 Porter?s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
    18.1 Research Methodology
        18.1.1 Methodology/Research Approach
        18.1.2 Data Source
    18.2 Disclaimer

Market Segmentation

By Type

  • Purity ≥ 98%
  • Purity ≥ 99%

By Application

  • Abiraterone Acetate Tablets
  • Abiraterone Acetate Capsules
  • Others

Regional Analysis

  • North America: U.S., Canada, Mexico
  • Europe: Germany, U.K., France, Italy, Russia, Spain, others
  • Asia-Pacific: China, India, Japan, Southeast Asia, others
  • South America: Brazil, Argentina, others
  • Middle East & Africa: Saudi Arabia, South Africa, others

Competitive Landscape

Top key players covered in the Abiraterone Acetate API market include:

  • Cipla
  • Tapi Teva
  • HETERO
  • Sterling S.P.A. IT
  • Farmhispania Group
  • Scion Pharm Taiwan
  • Qilu Pharmaceutical
  • Aurisco Pharmaceutical
  • Aspen Bio Pharma Labs
  • Shilpa Medicare Limited
  • Shandong Chuangxin Pharmaceutical Research and Development
  • Zhejiang Xianju Junye Pharmaceutical
  • Wuhan Sunrise Technology Development

Upto 24 to 48 hrs (Working Hours)

Upto 72 hrs max (Working Hours) - Weekends and Public Holidays

Single User License - Allows access to only one person to the report.

Multi User License - Allows sharing with max 5 persons within organization.

Corporate License – Can be shared across entire organization.

Online Payments with PayPal

Wire Transfer / Bank Transfer

Why Choose Us

24/7 Expert Support

At ChemReports, we understand that business decisions can’t wait. Our research specialists are available anytime to answer your queries and guide you through our reports, ensuring quick and reliable assistance.

Comprehensive Market Coverage

ChemReports provides 360° market analysis across materials, technologies, and global chemical sectors—helping you make confident business decisions.

Actionable Intelligence

We turn complex data into strategic insights to support fact-based decisions, market entry strategies, and competitive analysis.

Data Privacy & Security

Your personal and business information is completely secure with us. We value your trust and ensure strict confidentiality.

Customized Research

Need tailored insights? Our analysts provide custom reports built on authentic data and aligned with your specific business goals.

FAQs

Yes, we are providing all research support to get resolve all queries and concerns regarding the report. For all our clients.
Yes, we are providing complete customization in every report to fulfill your business needs.
Yes, we are providing regional and countries level analysis in the report, please mention the countries you are looking.
Yes, we are providing a discount for individuals and startups.
We offer access to more than one million market research reports. If the specific topic you need is not listed on our website, simply email us your requirements at sales@chemreports.com. Our research team will review your request and provide a customized report or the most relevant available study. We?re always happy to assist you with tailored solutions.